Prostate-specific membrane antigen (PSMA)-PET/CT imaging identified metastatic prostate cancer in almost half of high-risk cases missed by conventional imaging, a retrospective analysis showed.

One-third of patients with PSA levels below 0.2 ng/mL after radical prostatectomy have recurrent disease identifiable by PSMA PET. More than one-third of patients with PSA levels less than 0.5 ng/mL ...

Metastatic prostate cancer continues to decline in incidence, but the proportion of cases being diagnosed in younger men is increasing, according to a study. Researchers analyzed population-based ...

A critical task in oncology is extracting information related to cancer metastasis from electronic health records. Metastasis-related information is crucial for planning treatment, evaluating patient ...

Please provide your email address to receive an email when new articles are posted on . Incidence of distant-stage prostate cancer in California increased from 2011 to 2021. Prostate cancer mortality, ...